gender-affirming treatment

The Federal Trade Commission (FTC) and four states sued the World Professional Association for Transgender Health (WPATH) over allegations of misleading parents about the medical basis and safety of gender-affirming treatments for children. WPATH denied the claims, calling them baseless and asserting the FTC lacks jurisdiction over its medical guidelines.

The Federal Trade Commission and four states sued the World Professional Association for Transgender Health (WPATH) over allegations of misleading parents about the medical basis and safety of gender-affirming care for children. WPATH denied the claims, calling the lawsuit baseless and accusing the Trump administration of interfering in healthcare decisions. The nonprofit previously won a temporary court order halting an FTC investigation into its practices.

The Federal Trade Commission and four states sued the World Professional Association for Transgender Health (WPATH) over allegations of misleading parents about the medical basis, necessity, and safety of gender-affirming treatments for children. WPATH denied the claims, calling the lawsuit baseless and part of a broader effort to restrict access to transgender healthcare.

The Federal Trade Commission and four states sued the World Professional Association for Transgender Health (WPATH) for allegedly misleading parents about gender-affirming treatments. WPATH denied the claims, calling them baseless and part of an effort to interfere with healthcare rights. The lawsuit follows a previous legal battle where a federal judge temporarily paused an FTC investigation into WPATH.